| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.001 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.57 | 0.002 |